Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubonishi, I.
Right arrow Articles by Miyoshi, I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kubonishi, I.
Right arrow Articles by Miyoshi, I.

International Journal of Cell Cloning, Vol 1, 105-117, Copyright © 1983 by AlphaMed Press

ORIGINAL ARTICLES

Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis

I Kubonishi and I Miyoshi

A new hematopoietic cell line, designated KCL-22, was established in vitro by cultivation of pleural effusion cells obtained from a woman with chronic myelogenous leukemia in blast crisis. KCL-22 grew in suspension culture with a doubling time of 24 h and consisted of immature undifferentiated cells which were positive for periodic acid- Schiff and acid phosphatase staining. Chromosome analysis of the KCL-22 line showed a female karyotype with double Ph1 chromosomes and additional chromosome abnormalities. Its representative karyotype was 52,XX, + 1p-,+6,+8,+8,+8, t(9q+;22q-), +22q-. This cell line possessed receptors for the Fc portion of IgG, but lacked lymphoid cell characteristics and the Epstein-Barr virus-associated nuclear antigen. These results indicate that the KCL-22 cells were derived from chronic myelogenous leukemia cells. This cell line should prove useful for research involving various aspects of chronic myelogenous leukemia.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
P. La Rosee, T. Jia, S. Demehri, N. Hartel, P. de Vries, L. Bonham, D. Hollenback, J. W. Singer, J. V. Melo, B. J. Druker, et al.
Antileukemic Activity of Lysophosphatidic Acid Acyltransferase-{beta} Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib.
Clin. Cancer Res., November 1, 2006; 12(21): 6540 - 6546.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. Ikezoe, C. Nishioka, T. Tasaka, Y. Yang, N. Komatsu, K. Togitani, H. P. Koeffler, and H. Taguchi
The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling.
Mol. Cancer Ther., October 1, 2006; 5(10): 2522 - 2530.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Bandyopadhyay, T. Biswas, K. C. Roy, S. Mandal, C. Mandal, B. C. Pal, S. Bhattacharya, S. Rakshit, D. K. Bhattacharya, U. Chaudhuri, et al.
Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells
Blood, October 15, 2004; 104(8): 2514 - 2522.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
K. Ohmine, T. Nagai, T. Tarumoto, T. Miyoshi, K. Muroi, H. Mano, N. Komatsu, F. Takaku, and K. Ozawa
Analysis of Gene Expression Profiles in an Imatinib-Resistant Cell Line, KCL22/SR
Stem Cells, May 1, 2003; 21(3): 315 - 321.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Komatsu, T. Watanabe, M. Uchida, M. Mori, K. Kirito, S. Kikuchi, Q. Liu, T. Tauchi, K. Miyazawa, H. Endo, et al.
A Member of Forkhead Transcription Factor FKHRL1 Is a Downstream Effector of STI571-induced Cell Cycle Arrest in BCR-ABL-expressing Cells
J. Biol. Chem., February 14, 2003; 278(8): 6411 - 6419.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
V. Lacronique, A. Boureux, R. Monni, S. Dumon, M. Mauchauffe, P. Mayeux, F. Gouilleux, R. Berger, S. Gisselbrecht, J. Ghysdael, et al.
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells
Blood, March 15, 2000; 95(6): 2076 - 2083.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. H.A. Hermans, C. Antonissen, A. C. Ward, A. E.M. Mayen, R. E. Ploemacher, and I. P. Touw
Sustained Receptor Activation and Hyperproliferation in Response to Granulocyte Colony-stimulating Factor (G-CSF) in Mice with a Severe Congenital Neutropenia/Acute Myeloid Leukemia-derived Mutation in the G-CSF Receptor Gene
J. Exp. Med., February 15, 1999; 189(4): 683 - 692.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Hangaishi, S. Ogawa, K. Mitani, N. Hosoya, S. Chiba, Y. Yazaki, and H. Hirai
Mutations and Loss of Expression of a Mismatch Repair Gene, hMLH1, in Leukemia and Lymphoma Cell Lines
Blood, March 1, 1997; 89(5): 1740 - 1747.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. Collins, I Kubonishi, I Miyoshi, and M. Groudine
Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells
Science, July 6, 1984; 225(4657): 72 - 74.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.epitomics.com
Copyright © 1983 by AlphaMed Press.